Literature DB >> 29680871

Cystic tumors of the pituitary infundibulum: seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterization.

José M Pascual1, Ruth Prieto2, Maria Rosdolsky3, Sewan Strauss4, Inés Castro-Dufourny5, Verena Hofecker6, Eduard Winter6, Rodrigo Carrasco7, Walter Ulrich8.   

Abstract

A heterogeneous group of epithelial cystic tumors developed at the infundibulum and the third ventricle disconcerted pathologists at the dawn of the twentieth century. Very little was known at that time about the physiological role played by the pituitary gland, and there was almost complete ignorance regarding the function of the hypothalamus. Acromegaly, or enlargement of acral body parts, described in 1886 by Pierre Marie, was the only disease linked to primary hypertrophies of the pituitary gland, known as "pituitary strumas". A growing number of young patients manifesting an unexplained combination of physical and mental symptoms, including absent or delayed sexual maturation, progressive obesity, abnormal somnolence, and dementia-like changes in behavior were reported to present large solid-cystic tumors which characteristically expanded within the infundibulum and third ventricle, above an anatomically intact pituitary gland. Between 1899 and 1904, five seminal autopsy studies from different countries thoroughly described the anatomical relationships and histological features of this newly recognized type of infundibular tumors. These cases were instrumental in fostering the systematic investigation of similar lesions by the Austrian pathologist Jakob Erdheim (1874-1937), who in 1904 was able to classify these infundibulo-tuberal cysts under the common category of hypophyseal duct tumors. The pioneering American neurosurgeon Harvey Cushing (1869-1939) unsuccessfully attempted to surgically remove one of these cysts, for the first time in history, in 1902. The term "craniopharyngioma", chosen by Cushing in 1929 to designate these lesions, would eventually prevail over Erdheim's more accurate denomination, which linked their origin to squamous cell remnants derived from the embryological structures that give rise to the pituitary gland. This paper presents a comprehensive, renewed account of the five clinical-pathological reports which laid the groundwork for the proper clinical diagnosis, topographic conceptualization and pathological categorization of craniopharyngiomas.

Entities:  

Keywords:  Craniopharyngioma; Fröhlich’s syndrome; Hypothalamus; Infundibulum; Jakob Erdheim; Pituitary gland; Rathke’s pouch; Sir Frederick Mott

Mesh:

Year:  2018        PMID: 29680871     DOI: 10.1007/s11102-018-0889-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  16 in total

1.  Memory disturbances in third ventricle tumours.

Authors:  M WILLIAMS; J PENNYBACKER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-05       Impact factor: 10.154

2.  Sir Frederick Mott, K.B.E., M.D., F.R.C.P., F.R.S., LL.D.

Authors: 
Journal:  Br Med J       Date:  1926-06-19

3.  Jean Camus and Gustave Roussy: pioneering French researchers on the endocrine functions of the hypothalamus.

Authors:  Inés Castro-Dufourny; Rodrigo Carrasco; Ruth Prieto; José M Pascual
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

4.  I. Operations upon the Hypophysis.

Authors:  F V Eiselsberg
Journal:  Ann Surg       Date:  1910-07       Impact factor: 12.969

Review 5.  Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category.

Authors:  José M Pascual; Ruth Prieto; Rodrigo Carrasco
Journal:  Acta Neurochir (Wien)       Date:  2011-09-15       Impact factor: 2.216

6.  Sir Victor Horsley: pioneer craniopharyngioma surgeon.

Authors:  José M Pascual; Ruth Prieto; Paolo Mazzarello
Journal:  J Neurosurg       Date:  2015-02-20       Impact factor: 5.115

Review 7.  Infundibulo-tuberal syndrome: the origins of clinical neuroendocrinology in France.

Authors:  Inés Castro-Dufourny; Rodrigo Carrasco; Ruth Prieto; José M Pascual
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

8.  Harvey Cushing and pituitary Case Number 3 (Mary D.): the origin of this most baffling problem in neurosurgery.

Authors:  José María Pascual; Ruth Prieto
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

9.  The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal.

Authors:  M L Bernstein; J J Buchino
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1983-11

10.  Development of intracranial approaches for craniopharyngiomas: an analysis of the first 160 historical procedures.

Authors:  José María Pascual; Ruth Prieto; Inés Castro-Dufourny; Rodrigo Carrasco; Sewan Strauss; Laura Barrios
Journal:  Neurosurg Focus       Date:  2014-04       Impact factor: 4.047

View more
  4 in total

Review 1.  Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases.

Authors:  Ruth Prieto; Laura Barrios; José M Pascual
Journal:  Neurosurg Rev       Date:  2021-08-27       Impact factor: 3.042

2.  Duct-like diverticulum at the base of third ventricle tumors: a morphological signature diagnostic of papillary craniopharyngioma.

Authors:  José María Pascual; Ruth Prieto; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2022-08-19       Impact factor: 2.800

Review 3.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

4.  Reinvestigating Tumor-Ventricle Relationship of Craniopharyngiomas With Predominantly Ventricular Involvement: An Endoscopic Endonasal Series Based on Histopathological Assessment.

Authors:  Jun Fan; Yi Liu; Chaohu Wang; Zhanpeng Feng; Jun Pan; Yuping Peng; Junxiang Peng; Yun Bao; Jing Nie; Binghui Qiu; Songtao Qi
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.